Business / Finance

RSS

Concord Medical first quarter total net revenues increase 14.7% to $13.3 million

Concord Medical Services Holdings Limited, the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the first quarter ended March 31, 2011.

18 May 2011

Clinipace Worldwide announces acquisition of PFC

Clinipace Worldwide, a global digital clinical research organization, and Swiss-based PFC Pharma Focus today jointly announced a definitive merger agreement under which Clinipace Worldwide has acquired all outstanding shares of privately-held PFC and its subsidiaries.

18 May 2011

Ampio's common stock to be listed on NASDAQ Capital Market

Ampio Pharmaceuticals, Inc., a clinical stage developer of new uses for previously approved drugs and new molecular entities, announces that its common stock has been approved for listing on the NASDAQ Capital Market.

18 May 2011

Thermo Fisher Scientific acquires Dionex

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has successfully completed its acquisition of Dionex Corporation through a short-form merger.

From Thermo Fisher Scientific Inc. 18 May 2011

Excaliber subsidiary merges with VistaGen

Excaliber Enterprises, Ltd. announced today that its wholly-owned subsidiary has merged with VistaGen Therapeutics, Inc., a private biotechnology company focused on stem cell-based drug rescue and drug development. As a result of the Merger, VistaGen is a wholly-owned subsidiary of Excaliber.

17 May 2011

CryoLife acquires Cardiogenesis

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has successfully completed its acquisition of Cardiogenesis Corporation.

17 May 2011

Pernix first quarter net revenues increase 14% to $10.1 million

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company primarily focused on the pediatric market, today announced financial results for the first quarter of 2011.

17 May 2011

HASCO Medical acquires Wheelchair Vans of America and Mobility Freedom

HASCO Medical, Inc., a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, announced today its acquisition of Mobility Freedom Inc. and Wheelchair Vans of America.

17 May 2011

LifeVantage fiscal third quarter net revenue increases 270% to $10.0 million

LifeVantage Corporation, the maker of science-based solutions to oxidative stress, today, reported financial results for the third quarter and first nine months of fiscal 2011 ended March 31, 2011.

17 May 2011

Targacept proposes $75 million underwritten public offering of common stock

Targacept, Inc. announced today that it is offering to sell $75 million in shares of its common stock in an underwritten public offering. Targacept expects to grant the underwriters for the offering an option to purchase additional shares of common stock to cover over-allotments, if any.

17 May 2011

Columbia Laboratories to be listed on NASDAQ Biotechnology Index

Columbia Laboratories, Inc. today announced the Company will be added to the NASDAQ Biotechnology Index.

17 May 2011

American Heart Association recognizes NIC as Platinum-Level Start! Fit-Friendly Company

NIC, a leading provider of online government services, is one of only two Kansas City metro companies to be recognized as a Platinum-Level Start! Fit-Friendly Company by the American Heart Association's Start! initiative for helping employees eat better and move more.

17 May 2011

Business trends shape medical practices

Minnesota Public Radio reports that independent practices increasingly face an uphill battle while the Minneapolis Star Tribune notes that the "company doctor" is making a comeback in workplaces across the nation.

17 May 2011

Thermo Fisher Scientific announces completion of Dionex tender offer

Thermo Fisher Scientific, the world leader in serving science, today announced that it has successfully completed its tender offer for Dionex Corporation.

From Thermo Fisher Scientific Inc. 17 May 2011

CytRx sells global rights of molecular chaperone assets to Orphazyme

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has sold the worldwide rights to its molecular chaperone assets to privately-held, Copenhagen, Denmark-based Orphazyme ApS.

17 May 2011

Eli Lilly responds to Amylin's exenatide lawsuit

Eli Lilly and Company has provided additional perspective in response to Amylin Pharmaceuticals, Inc.'s lawsuit filed in the United States District Court for the Southern District of California.

17 May 2011

Epichem signs exclusive distributor agreement with AR Brown

Australian supplier of API analytical standards Epichem, announced today it has signed an exclusive distributor agreement with a leading Japanese Life Sciences supplier company, AR Brown, for sales to Japan, Taiwan, China and South Korea.

17 May 2011

Comprehensive Care first quarter total revenue increases 383% to $18.3 million

Comprehensive Care Corporation today reported results for the first quarter ended March 31, 2011.

17 May 2011

Merck acquires Inspire Pharmaceuticals

Merck, known as MSD outside the United States and Canada, announced today that it is has completed its acquisition of Inspire Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing ophthalmic products, for $5.00 per share in cash.

17 May 2011

Histogenics announces acquisition of ProChon Biotech

Histogenics Corporation, a privately held regenerative medicine company, announced today that it has acquired ProChon Biotech, Ltd. in a stock-for-stock exchange.

17 May 2011